Literature DB >> 4934348

The effect of cytotoxic drugs on graft-versus-host disease in mice.

A H Owens, G W Santos.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 4934348     DOI: 10.1097/00007890-197104000-00004

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


× No keyword cloud information.
  19 in total

1.  Biological effects of cyclosporin A: a new antilymphocytic agent.

Authors:  J F Borel; C Feurer; H U Gubler; H Stähelin
Journal:  Agents Actions       Date:  1976-07

2.  Pharmacologic manipulation of graft versus host induced splenomegaly.

Authors:  R E Roudebush; H U Bryant
Journal:  Agents Actions       Date:  1992-03

Review 3.  Experimental bone marrow transplantation.

Authors:  S Thierfelder
Journal:  Blut       Date:  1975-01

Review 4.  Haploidentical hematopoietic stem cell transplantation: state of art.

Authors:  Y Reisner; F Aversa; M F Martelli
Journal:  Bone Marrow Transplant       Date:  2015-06       Impact factor: 5.483

Review 5.  Application of marrow grafts in human disease.

Authors:  G W Santos
Journal:  Am J Pathol       Date:  1971-12       Impact factor: 4.307

6.  Cyclophosphamide and human organ transplantation.

Authors:  T E Starzl; C G Halgrimson; I Penn; G Martineau; G Schroter; H Amemiya; C W Putnam; C G Groth
Journal:  Lancet       Date:  1971-07-10       Impact factor: 79.321

7.  Biological effects of cyclosporin A: a new antilymphocytic agent. 1976.

Authors:  J F Borel; C Feurer; H U Gubler; H Stähelin
Journal:  Agents Actions       Date:  1994-12

8.  The capacity of microsomally-activated cyclophosphamide to induce immunosuppression in vitro.

Authors:  F L Shand
Journal:  Immunology       Date:  1978-12       Impact factor: 7.397

Review 9.  Halfway there: the past, present and future of haploidentical transplantation.

Authors:  M Slade; B Fakhri; B N Savani; R Romee
Journal:  Bone Marrow Transplant       Date:  2016-07-25       Impact factor: 5.483

10.  HLA-haploidentical bone marrow transplantation for hematologic malignancies using nonmyeloablative conditioning and high-dose, posttransplantation cyclophosphamide.

Authors:  Leo Luznik; Paul V O'Donnell; Heather J Symons; Allen R Chen; M Susan Leffell; Marianna Zahurak; Ted A Gooley; Steve Piantadosi; Michele Kaup; Richard F Ambinder; Carol Ann Huff; William Matsui; Javier Bolaños-Meade; Ivan Borrello; Jonathan D Powell; Elizabeth Harrington; Sandy Warnock; Mary Flowers; Robert A Brodsky; Brenda M Sandmaier; Rainer F Storb; Richard J Jones; Ephraim J Fuchs
Journal:  Biol Blood Marrow Transplant       Date:  2008-06       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.